-+ 0.00%
-+ 0.00%
-+ 0.00%

REFILE-XENON PHARMACEUTICALS SHARES FALL 27.5% PREMARKET AFTER CO PAUSES NEW ENROLLMENT IN DEPRESSION DRUG TRIALS (FIXES TYPO IN SHARE PRICE)

Reuters·09/18/2026 08:12:01